• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素治疗痉挛

Treatment of spasticity with botulinum toxin.

作者信息

O'Brien Christopher F

机构信息

Elan Pharmaceuticals, San Diego, California 92121, USA.

出版信息

Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S182-90. doi: 10.1097/00002508-200211001-00011.

DOI:10.1097/00002508-200211001-00011
PMID:12569967
Abstract

Spasticity is an abnormal increase in muscle contraction often caused by damage to central motor pathways that control voluntary movement. During clinical examination, spasticity manifests as an increase in stretch reflexes, producing tendon jerks and resistance appearing as muscle tone. There are many causes of spasticity, including demyelination from multiple sclerosis, congenital damage from diseases such as cerebral palsy, trauma to the brain or spinal cord, hemorrhage or infarction, and other pathologic conditions that interrupt neural pathways. Effects of spasticity range from mild muscle stiffness to severe, painful muscle contractures and repetitive spasms that reduce mobility and substantially impede normal activities of daily living. Botulinum toxin therapy reduces spasticity and pain associated with several disorders. Local treatment with botulinum toxins can be used as adjunctive therapy, along with oral antispasticity medications, or alone to provide localized decrease in symptoms of spasticity and pain. Botulinum toxin therapy may be particularly useful for patients with spasticity due to stroke, whose treatment can be tailored based on recovery of function over time. In addition, botulinum toxin therapy is safe for pediatric patients, including children with cerebral palsy, who may not be able to tolerate the cognitive side effects of oral medications. Results of studies evaluating botulinum toxin for the treatment of spasticity due to various causes are presented here.

摘要

痉挛是肌肉收缩异常增加,通常由控制自主运动的中枢运动通路受损引起。在临床检查中,痉挛表现为牵张反射增强,产生腱反射亢进,且阻力以肌张力的形式出现。痉挛有多种病因,包括多发性硬化导致的脱髓鞘、脑瘫等疾病引起的先天性损伤、脑或脊髓外伤、出血或梗死,以及其他中断神经通路的病理状况。痉挛的影响范围从轻度肌肉僵硬到严重的、疼痛性肌肉挛缩以及重复性痉挛,这些会降低活动能力并严重妨碍正常的日常生活活动。肉毒毒素疗法可减轻与多种疾病相关的痉挛和疼痛。肉毒毒素局部治疗可作为辅助疗法,与口服抗痉挛药物联合使用,或单独使用以局部减轻痉挛和疼痛症状。肉毒毒素疗法对因中风导致痉挛的患者可能特别有用,其治疗可根据功能随时间的恢复情况进行调整。此外,肉毒毒素疗法对儿科患者是安全的,包括患有脑瘫的儿童,他们可能无法耐受口服药物的认知副作用。本文介绍了评估肉毒毒素治疗各种病因所致痉挛的研究结果。

相似文献

1
Treatment of spasticity with botulinum toxin.肉毒杆菌毒素治疗痉挛
Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S182-90. doi: 10.1097/00002508-200211001-00011.
2
Use of botulinum toxin type A and type B for spasticity in upper and lower limbs.A型和B型肉毒杆菌毒素用于治疗上肢和下肢痉挛。
Phys Med Rehabil Clin N Am. 2003 Nov;14(4):821-35. doi: 10.1016/s1047-9651(03)00064-0.
3
Botulinum toxin and spasticity.肉毒杆菌毒素与痉挛
J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):143-7. doi: 10.1136/jnnp.69.2.143.
4
Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.儿童脑瘫相关的痉挛状态:A型肉毒毒素使用指南
Paediatr Drugs. 2003;5(1):11-23. doi: 10.2165/00128072-200305010-00002.
5
[Spasticity and botulinum toxin in 2003. An update].[2003年的痉挛状态与肉毒杆菌毒素。最新情况]
Neurochirurgie. 2003 May;49(2-3 Pt 2):265-70.
6
Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.肉毒杆菌神经毒素肌肉内化学去神经支配。在痉挛性肌张力亢进及相关运动障碍管理中的作用。
Phys Med Rehabil Clin N Am. 2001 Nov;12(4):833-74, vii-viii.
7
Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.超声评估肉毒杆菌毒素治疗小儿脑性瘫痪下肢痉挛时腓肠肌肌肉结构的变化
J Orthop Sci. 2018 Mar;23(2):389-393. doi: 10.1016/j.jos.2017.10.012. Epub 2017 Nov 14.
8
Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.A型肉毒杆菌毒素对上肢痉挛型脑瘫的影响。
Am J Phys Med Rehabil. 2003 Apr;82(4):284-9. doi: 10.1097/01.PHM.0000056989.67763.07.
9
[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].[肉毒杆菌毒素治疗多发性硬化症患者的髋内收肌痉挛]
Wien Klin Wochenschr. 2001;113 Suppl 4:20-4.
10
Spinal cord injury and use of botulinum toxin in reducing spasticity.脊髓损伤与肉毒杆菌毒素在减轻痉挛方面的应用。
Phys Med Rehabil Clin N Am. 2003 Nov;14(4):901-10. doi: 10.1016/s1047-9651(03)00097-4.

引用本文的文献

1
Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review.肉毒杆菌神经毒素:历史、作用机制及应用。一篇叙述性综述。
J Neurochem. 2025 Aug;169(8):e70187. doi: 10.1111/jnc.70187.
2
The 3D muscle morphology and intramuscular innervation of the digital bellies of flexor digitorum profundus: Clinical implications for botulinum toxin injection sites.屈指深肌指腹的三维肌肉形态和肌内神经支配:肉毒毒素注射部位的临床意义。
J Anat. 2024 Apr;244(4):610-619. doi: 10.1111/joa.13986. Epub 2023 Dec 20.
3
The Isolated Mouse Jejunal Afferent Nerve Assay as a Tool to Assess the Effect of Botulinum Neurotoxins in Visceral Nociception.
孤立小鼠空肠传入神经测定法作为评估肉毒杆菌神经毒素对内脏痛觉影响的工具
Toxins (Basel). 2022 Mar 11;14(3):205. doi: 10.3390/toxins14030205.
4
Effectiveness of Treatment in Children With Cerebral Palsy.脑瘫患儿的治疗效果
Cureus. 2021 Mar 7;13(3):e13754. doi: 10.7759/cureus.13754.
5
Early brain imaging predictors of post-stroke spasticity.脑卒中后痉挛的早期脑影像学预测指标。
J Rehabil Med. 2021 Mar 22;53(3):jrm00169. doi: 10.2340/16501977-2803.
6
Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity: results from the double-blind, placebo-controlled, phase 3 REFLEX study.脑卒后下肢痉挛成人患者早期接受依降钙素原治疗的影响:REFLEX 双盲、安慰剂对照、3 期研究结果。
J Neural Transm (Vienna). 2020 Dec;127(12):1619-1629. doi: 10.1007/s00702-020-02251-6. Epub 2020 Oct 27.
7
Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study.多发性硬化症中肉毒杆菌毒素停药的决定因素:一项回顾性研究。
Neurol Sci. 2017 Oct;38(10):1841-1848. doi: 10.1007/s10072-017-3078-3. Epub 2017 Aug 1.
8
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.肉毒杆菌毒素治疗多发性硬化症中的痉挛:IAB-运动障碍跨学科工作组特别工作组的综述与建议
J Neurol. 2017 Jan;264(1):112-120. doi: 10.1007/s00415-016-8304-z. Epub 2016 Oct 27.
9
Long-term follow-up after botulinum toxin A (BTX-A) injection into the detrusor for treatment of neurogenic detrusor hyperactivity in children.肉毒杆菌毒素A(BTX-A)注射入逼尿肌治疗儿童神经源性逼尿肌过度活动后的长期随访
Cent European J Urol. 2012;65(3):156-61. doi: 10.5173/ceju.2012.03.art12. Epub 2012 Sep 4.
10
Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review.成人下肢痉挛的疾病流行病学、人文及经济负担:一项系统综述
Neuropsychiatr Dis Treat. 2014 Jan 23;10:111-22. doi: 10.2147/NDT.S53913. eCollection 2014.